<meta http-equiv="Content-Type" content="text/html;charset=utf-8" /><!DOCTYPE doctype html>
<html class="Unknown 0_0 Unknown Unknown titanDisplay" id="htmlTag" xmlns="http://www.w3.org/1999/xhtml">
 <head>
  <link href="/ClientCss/style_eperc.css" rel="stylesheet" type="text/css"/>
  <meta content="Titan CMS" name="creator"/>
  <title id="pageTitle">
   # 086 Methadone: Starting Dosing Information, 2nd ed
  </title>
  <meta content="72473" name="DocID">
   <meta content="# 086 Methadone: Starting Dosing Information, 2nd ed" name="Title">
    <meta content="# 086 Methadone: Starting Dosing Information, 2nd ed, Medical Knowledge, Pain – Opioids, Patient Care" name="Keywords">
     <meta content="" name="Description">
      <meta content="" name="Abstract">
       <link href="/display/WhatsNew.rss" rel="alternate+rss" title="RSS" type="application/rss+xml"/>
       <script src="/Scripts/titanscripts.js" type="text/javascript">
       </script>
       <script src="/Scripts/Banner.js" type="text/javascript">
       </script>
       <script src="http://www.google.com/recaptcha/api/js/recaptcha_ajax.js" type="text/javascript">
       </script>
       <script src="/commonScripts/mcwCommon.js" type="text/javascript">
       </script>
       <script type="text/javascript">
        var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
       </script>
       <script type="text/javascript">
        try {
var pageTracker = _gat._getTracker("UA-11124256-1");
pageTracker._trackPageview();
} catch(err) {}
       </script>
      </meta>
     </meta>
    </meta>
   </meta>
  </meta>
 </head>
 <body class="titanBody" id="bodyTag" onclick="if (window['TitanClickHandler']) TitanClickHandler(this, event)" onload="TitanLoad();">
  <form action="/EPERC/FastFactsIndex/ff_086.htm?" enctype="multipart/form-data" id="routerForm" method="post" name="routerForm">
   <input id="__VIEWSTATE" name="__VIEWSTATE" type="hidden" value="/wEPDwUJMzU4NzMwNDI4D2QWAgIBDxYCHgVjbGFzcwUpVW5rbm93biAwXzAgVW5rbm93biBVbmtub3duICB0aXRhbkRpc3BsYXkWCAIKDxYCHgRUZXh0BWc8c2NyaXB0IHNyYz0naHR0cDovL3d3dy5nb29nbGUuY29tL3JlY2FwdGNoYS9hcGkvanMvcmVjYXB0Y2hhX2FqYXguanMnIHR5cGU9J3RleHQvamF2YXNjcmlwdCc+PC9zY3JpcHQ+ZAIMDxYCHwFkZAIODxYCHwFlZAISDxYEHgZvbmxvYWQFDFRpdGFuTG9hZCgpOx4Hb25jbGljawU/aWYgKHdpbmRvd1snVGl0YW5DbGlja0hhbmRsZXInXSkgVGl0YW5DbGlja0hhbmRsZXIodGhpcywgZXZlbnQpFgICAQ9kFgQCAw9kFgJmD2QWBAIRDxQrAANkZGRkAhUPFCsAAmRkZAIFDxYCHwEF5gI8aW5wdXQgdHlwZT0naGlkZGVuJyBpZD0nZmxvd1BsYXllclNldHRpbmdzJyBiYXNlRGlyPScvZGlzcGxheS9jb21wb25lbnRzL0Jsb2Nrcy9GcmVlZm9ybV9DSy9ja2VkaXRvci9wbHVnaW5zL3RpdGFuZmxvd3BsYXllci8nIGpzPSdmbG93cGxheWVyLTMuMi4xMS5taW4uanMnIHN3Zj0nZmxvd3BsYXllci0zLjIuMTIuc3dmJyBwc2V1ZG89J2Zsb3dwbGF5ZXIucHNldWRvc3RyZWFtaW5nLTMuMi45LnN3ZicgIE1vZGVybj0nZmxvd3BsYXllci5jb250cm9scy0zLjIuMTIuc3dmJyBBaXI9J2Zsb3dwbGF5ZXIuY29udHJvbHMtYWlyLTMuMi4xMi5zd2YnIFR1YmU9J2Zsb3dwbGF5ZXIuY29udHJvbHMtdHViZS0zLjIuMTIuc3dmJy8+ZGSumZjFZ7CvAwS4t8L1/BwlXprlAqtFx3o9gzH3UyMfgg=="/>
   <script src="/ScriptResource.axd?d=xFDxeqDolrWHepB5BOa6WusqXFLn3wro2JYAUSW54WCZIM7tlRS9tbqUciiQ66IHFJNcNWN3CVU9VVXPPRcSENg7qOCQHN4cE4-dXQ8bxlvvzOwDdwbXgIu1gG27qPOQ1CQrIgFe_q5BlrAijrvDUgIWykSGToLqgYeMH1AtHUs1&amp;t=ffffffff940d030f" type="text/javascript">
   </script>
   <script src="/display/components/Blocks/Commenting/Support/CommentingAjax.asmx/js" type="text/javascript">
   </script>
   <div id="mainBody">
    <!--/pageTopArea -->
    <div id="contentArea">
     <div id="contentContainer">
      <!--/toolContainer -->
      <div id="centerZone">
       <div id="titleBarContainer">
        <h1>
         # 086 Methadone: Starting Dosing Information, 2nd ed
        </h1>
       </div>
       <!--/titleBarContainer -->
       <div blockinfo="Freeform CenterZone BlockID1" class="Freeform CenterZone BlockID1">
        <h4>
         <a href="/FileLibrary/User/jrehm/fastfactpdfs/Concept086.pdf" linktype="4" target="_blank">
          FAST FACTS AND CONCEPTS #086 PDF
         </a>
        </h4>
        <p>
         <br/>
         <b>
          Author(s):
         </b>
         Charles F von Gunten MD
        </p>
        <p>
         <b>
          Background
         </b>
         Methadone is an effective opioid analgesic for severe pain. Because of low cost (a month’s supply may be US $5-10) and apparent efficacy in complex pain syndromes, it is increasingly used as a first-line opioid. It is, in effect, a combination drug – part opioid and part NMDA receptor antagonist – although there is yet to be any evidence from controlled trials that it is a superior first-line analgesic to other opioids. Methods of dose conversion to methadone from other opioid analgesics that account for its dual action were discussed in
         <a href="/FileLibrary/User/jrehm/fastfactpdfs/Concept075.pdf" linktype="4" target="_blank">
          Fast Fact # 75
         </a>
         . A future Fast Fact will discuss different protocols for switching to methadone from other opioids. This Fast Fact will describe strategies for beginning methadone when the patient has not been taking a strong opioid.
         <b>
          Note:
         </b>
         due to its complex pharmacology, physicians unfamiliar with methadone are advised to seek consultation prior to initiating therapy (see
         <a href="/FileLibrary/User/jrehm/fastfactpdfs/Concept171.pdf" linktype="4" target="_blank">
          Fast Fact #171
         </a>
         ).
        </p>
        <p>
         <b>
          Pharmacology
         </b>
         Methadone is lipophilic, thus it takes time to develop tissue stores that maintain serum levels. There is enormous interindividual variation in how long this takes. After a single dose there is a short distribution phase (associated with acute pain relief) with a half-life of 2-3 hours and a slow elimination phase (half-life 15-60 hours). Dosing must account for the accumulation of drug over days. It is this accumulation that accounts for most therapeutic misadventures. Liver metabolites are inactive; therefore no dose reduction is required with renal failure. After steady-state is reached, about two-thirds of patients will get adequate pain relief with twice a day dosing.
         <b>
          Note:
         </b>
         a number of drugs will alter methadone metabolism, so there needs to be close follow-up and attention to the addition or subtraction of interacting medications.
        </p>
        <p>
         There are several approaches to starting methadone for the treatment of pain. All take into account the long-half life of the drug that leads to drug accumulation over days. The following discussion presents approaches based on the literature and the author’s clinical experiences.
        </p>
        <p>
         <b>
          Conservative Approach
         </b>
        </p>
        <ol type="a">
         <li>
          Begin fixed dose methadone 5 or 10 mg orally bid or tid for 4-7 days.
         </li>
         <li>
          If incomplete pain relief, increase the dose by 50% and continue for 4-7 days.
         </li>
         <li>
          Continue increasing dose every 4-7 days until stable pain relief achieved.
         </li>
         <li>
          <u>
           Breakthrough pain:
          </u>
          use an alternative short acting oral opioid with short half-life (e.g. morphine 10 mg) every 1 h PRN for breakthrough pain and to provide pain relief during titration phase. This dose too may need to be titrated based on efficacy.
         </li>
        </ol>
        <p>
         <b>
          Loading Dose Approach
         </b>
        </p>
        <ol type="a">
         <li>
          Load: Start methadone at fixed oral dose (e.g. 5 or 10 mg) q 4h
          <b>
           PRN only
          </b>
          .
         </li>
         <li>
          Calculate Maintenance: On day 8, calculate the total methadone dosage taken over the last 24 hour period and give that in scheduled, divided doses bid or tid. Give 10% of total daily methadone as PRN drug q1h for breakthrough pain. Instruct the patient to call you if they need to use more than 5 breakthrough doses per day.
          <i>
           Example:
          </i>
          if someone took a total of 45 mg methadone on day 7 they would be converted to 15 mg tid scheduled with 5 mg as the prn dose.
         </li>
        </ol>
        <p>
         <b>
          References
         </b>
        </p>
        <ol>
         <li>
          Bruera E, Sweeney C. Methadone use in cancer patients with pain: a review. J Pall Med. 2002; 5:127-138.
         </li>
         <li>
          Bruera E, et al. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind Study. J Clin Oncol. 2004; 22:185-92.
         </li>
        </ol>
        <p>
         <b>
          Fast Facts and Concepts
         </b>
         are edited by Drew A Rosielle MD, Palliative Care Center, Medical College of Wisconsin. For more information write to:
         <a href="mailto:www.drosiell@mcw.edu?subject=EPERC%20Fast%20Facts%20and%20Concepts" linktype="5" target="_self">
          drosiell@mcw.edu
         </a>
         . More information, as well as the complete set of Fast Facts, are available at EPERC:
         <a href="http://www.eperc.mcw.edu" linktype="3" target="_blank">
          www.eperc.mcw.edu
         </a>
         .
        </p>
        <p>
         <b>
          Version History:
         </b>
         This Fast Fact was originally edited by David E Weissman MD. 2nd Edition was edited by Drew A Rosielle and published October 2007. Current version re-copy-edited April 2009.
        </p>
        <p>
         <b>
          Copyright/Referencing Information:
         </b>
         Users are free to download and distribute Fast Facts for educational purposes only. Von Gunten CF. Methadone: Starting Dose Information, 2nd Edition. Fast Facts and Concepts. October 2007; 86. Available at:
         <a href="http://www.eperc.mcw.edu/EPERC/FastFactsIndex/ff_086.htm">
          http://www.eperc.mcw.edu/EPERC/FastFactsIndex/ff_086.htm
         </a>
         .
        </p>
        <p>
         <b>
          Disclaimer:
         </b>
         Fast Facts and Concepts provide educational information. This information is not medical advice. Health care providers should exercise their own independent clinical judgment. Some Fast Facts cite the use of a product in a dosage, for an indication, or in a manner other than that recommended in the product labeling. Accordingly, the official prescribing information should be consulted before any such product is used.
        </p>
        <p>
         <b>
          ACGME Competencies:
         </b>
         Medical Knowledge, Patient Care
        </p>
        <p>
         <b>
          Keyword(s):
         </b>
         Pain – Opioids
        </p>
       </div>
      </div>
      <!--/centerZone -->
      <div id="rightZone">
      </div>
      <!--/rightZone -->
     </div>
     <!--/contentContainer -->
    </div>
    <!-- /contentArea -->
    <!--/bottomContainer -->
   </div>
   <!--/mainBody -->
   <input air="flowplayer.controls-air-3.2.12.swf" basedir="/display/components/Blocks/Freeform_CK/ckeditor/plugins/titanflowplayer/" id="flowPlayerSettings" js="flowplayer-3.2.11.min.js" modern="flowplayer.controls-3.2.12.swf" pseudo="flowplayer.pseudostreaming-3.2.9.swf" swf="flowplayer-3.2.12.swf" tube="flowplayer.controls-tube-3.2.12.swf" type="hidden"/>
  </form>
 </body>
</html>
